Patterns of epidermal growth factor receptor amplification in malignant gliomas

American Journal of Pathology

Volumn 148, Issue 4, 1996, Pages 1047-1053

  Sauter, Guido ^a,b   Maeda, Tatsuhiro ^a   Waldman, Frederic M ^a   Davis, Richard L ^a   Feuerstein, Burt G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BRAIN TUMOR; CANCER GRADING; CHROMOSOME 7; DOUBLE MINUTE CHROMOSOME; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; POLYSOME; PRIORITY JOURNAL;

BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 7; GENE AMPLIFICATION; GLIOBLASTOMA; GLIOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0029964091     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Prados MD, Gutin PH, Phillips TL, Wara WM, Larson DA, Sneed PK, Davis RL, Ahn DK, Lambom K, Wilson CB: Highly anaplastic astrocytoma, a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 1992, 23:3-8
2. Bigner SH, Mark J, Bigner DD Cytogenetics of human brain tumors. Cancer Genet Cytogenet 1990, 47:141-154
3. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, Cowan JM, Rowley JD, Diaz MO. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 1992, 52: 2523-2529
4. Frankel RH, Bayona W, Koslow M, Newcomb EW. p53 mutations in human malignant gliomas: Comparison of loss of heterozygosity with mutation frequency. Cancer Res 1992, 52:1427-1433
5. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 1992, 52:674-679
6. James CD, Carlborn E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK: Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988, 48.5546-5551
7. Fults D, Pedone CA, Thomas GA, White R: Allelotype of human malignant astrocytoma Cancer Res 1990, 50: 5784-5789
8. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ, Vogelstein B Identification of an amplified, highly expressed gene in a human glioma. Science 1987, 236:70-73
9. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 1987, 84:6899-6903
10. Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res 1988, 48.2231-2238
11. Chaffanet M, Chauvin C, Laine M, Berger F, Chedin M, Rost N, Nissou MF, Benabid AL: EGF receptor amplification and expression in human brain tumours. Eur J Cancer 1992, 28:11-17
12. Ekstrand AJ, Longo N, Hamid ML, Olson JJ, Liu L, Collins VP, James CD: Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 1994, 9:2313-2320
13. Hurtt MR, Moossy J, Donovan-Peluso M, Locker J. Amplification of epidermal growth factor receptor gene in gliomas, histopathology and prognosis. J Neuropathol Exp Neurol 1992, 51.84-90
14. Torp SH, Helseth E, Dalen A, Unsgaard G Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochir (Wien) 1992, 117:182-186
15. Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, Waldman F Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer, Int J Cancer 1994, 57:508-514
16. Colombatti M, Dipasquale B, Del-L'Arciprete L, Gerosa M, Tridente G. Heterogeneity and modulation of tumor-associated antigens in human glioblastorna cell lines. J Neurosurg 1989, 71:388-397
17. Von Hoff DD, McGill JR, Forseth BJ, Davidson KK, Bradley TP, Van Devanter DR, Wahl GM. Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity Proc Natl Acad Sci USA 1992, 89:8165-8169
18. Rey JA, Bello MJ, deCampos JM, Kusak ME, Moreno S: Cytogenetics following from direct preparation to advanced in vitro passages of a human malignant glioma. Cancer Genet Cytogenet 1989, 38:133-135
19. Mohapatra G, Kim DH, Feuerstein BG. Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization Genes Chromosomes & Cancer 1995, 13:86-93
20. Strommer K, Hamou MF, Diggelmann H, de Tribolet N: Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas. Acta Neurochir (Wien) 1990, 107.82-87
21. Torp SH, Helseth E, Ryan L, Stolan S, Dalen A, Unsgaard G: Amplification of the epidermal growth factor receptor gene in human gliomas. Anticancer Res 1991, 11 2095-2098
22. Schlegel J, Merdes A, Stumin G, Albert FK, Forsting M, Hynes N, Kiessling M: Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 1994, 56:72-77
23. Cavenee WK, Scrable HJ, James CD: Molecular genetics of human cancer predisposition and progression. Mutat Res 1991, 247 199-202
24. Walker RA, Camplejohn RS: DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors J Pathol 1986, 150:37-42
25. Kearsley JH, Furlong KL, Cooke RA, Waters MJ: An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br J Cancer 1990, 61:821-827
26. Toi M, Nakamura T, Mukaida H, Wada T, Osaki A, Yamada H, Toge T, Niimoto M, Hattori T: Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer Cancer 1990, 65:1980-1984
27. Bilous M, Milliken J, Mathijs JM: Immunocytochemistry and in situ hybridisation of epidermal growth factor receptor and relation to prognostic factors in breast cancer. Eur J Cancer 1992, 28A: 1033-1037
28. Wrba F, Reiner A, Ritzinger E, Holzner JH, Reiner G: Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study. Pathol Res Pract 1988, 183:25-29
29. Betta PG, Robutti F, Spinoglio G, Bottero G Expression of epidermal growth factor receptor in human breast carcinoma and its correlation with morphological and biological features of tumour aggressiveness. Pathologica 1989, 81:425-431
30. Bevilacqua P, Gaspanni G, Dal Fior S, Corradi G. Immunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients. Oncology 1990, 47313-47317
31. Gasparini G, Bevilacqua P, Dal Fior S, Panizzoni GA, Favretto S, Visona A, Meli S. Characterization of node-negative breast cancer by clinico-pathologic and biologic factors Anticancer Res 1990, 10:205-208
32. Gasparini G, Pozza F, Meli S, Reitano M, Santini G, Bevilacqua P. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness. Anticancer Res 1991, 11 2015-2021
33. Limas C, Bair R, Bernhart P, Reddy P: Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors. J Clin Pathol 1993, 46.810-816
34. Reifenberger G, Prior R, Deckert M, Wechsler W: Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system Virchows Arch A Pathol Anat Histopathol 1989, 414:147-155